Status of work in May
AOTMiT begins work on the Ministry of Health’s orders in May:
- Breyanziv (lisocabtagene maraleuce) for the treatment of patients with B-cell lymphomas
- Blincyto (blinatumomab) in the treatment of patients with acute lymphoblastic leukemia
- Staloral 300, a mixture of allergen extracts for the treatment of children with moderate to severe allergic rhinitis
- Ryeqo (relugolix, estradiol, norethisterone acetate) w objawowym leczeniu endometriozy u dorosłych kobiet
- Buccolam (midazolam) in the treatment of acute seizures
- Bimzelx (bimekizumab) in the treatment of patients with purulent inflammation of the apocrine sweat glands
- Leqvio (inclisiran) in the treatment of patients with lipid disorders
The listed orders are available on the AOTMiT Public Information Bulletin.